Clinical Trial

Golimumab for Adherence in Rheumatoid Arthritis

Study Description

Golimumab for Adherence in Rheumatoid Arthritis

The purpose of this study is to determine if non-adherence to Rheumatoid Arthritis (RA) drugs in participants treated with biologic disease modifying anti-rheumatic drugs (DMARDs) is associated with a greater incidence of disease in clinical practice.

Location

Locations Selected Location

Methods

No pharmaceutical medication involved No pharmaceutical medication involved
Recruiting patients only Recruiting patients only

Biological - Golimumab

Participants will receive golimumab as a part of clinical practice.

Additional Information

Official Study Title

Golimumab for Adherence in Rheumatoid Arthritis

Clinical Trial ID

NCT03729349

ParticipAid ID

e1wYjb